Process for producing GM2 specific antibodies
US6057115A · kind A · utility
13Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 1995 |
| Grant date | May 2, 2000 |
| Priority date | — |
| Expiry date | Jun 16, 2015 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2400/50
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to the production of ganglioside specific antibodies. These antibodies are produced following immunization with lipopolysaccharide antigen of Campylobacter jejuni. The antibodies bind to monosialogangliosides, including GM2 and GM1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.